LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | HG-5-88-01 | 10 | uM | LJP6 | 3 | A19 | 72 | hr | 1311 | 2648 | 4973 | 0.5324 | 0.4410 |
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 1 | M06 | 72 | hr | 1311 | 4562 | 4870 | 0.9367 | 0.9321 |
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 2 | M06 | 72 | hr | 1311 | 4562 | 4961 | 0.9195 | 0.9144 |
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 3 | M06 | 72 | hr | 1311 | 4585 | 4973 | 0.9218 | 0.9171 |
MDA-MB-231 | HG-6-64-01 | 0.12 | uM | LJP6 | 1 | M05 | 72 | hr | 1311 | 4624 | 4870 | 0.9494 | 0.9459 |
MDA-MB-231 | HG-6-64-01 | 0.12 | uM | LJP6 | 2 | M05 | 72 | hr | 1311 | 4806 | 4961 | 0.9686 | 0.9671 |
MDA-MB-231 | HG-6-64-01 | 0.12 | uM | LJP6 | 3 | M05 | 72 | hr | 1311 | 4830 | 4973 | 0.9711 | 0.9697 |
MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 1 | M04 | 72 | hr | 1311 | 4027 | 4870 | 0.8269 | 0.8089 |
MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 2 | M04 | 72 | hr | 1311 | 4154 | 4961 | 0.8372 | 0.8232 |
MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 3 | M04 | 72 | hr | 1311 | 4222 | 4973 | 0.8489 | 0.8366 |
MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 1311 | 2459 | 4870 | 0.5049 | 0.3938 |
MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 1311 | 2630 | 4961 | 0.5301 | 0.4368 |
MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 1311 | 2509 | 4973 | 0.5044 | 0.4011 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 1 | M02 | 72 | hr | 1311 | 1771 | 4870 | 0.3636 | 0.1719 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 2 | M02 | 72 | hr | 1311 | 2128 | 4961 | 0.4289 | 0.2867 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 3 | M02 | 72 | hr | 1311 | 1805 | 4973 | 0.3629 | 0.1806 |
MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 1 | M01 | 72 | hr | 1311 | 831 | 4870 | 0.1706 | -0.2143 |
MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 2 | M01 | 72 | hr | 1311 | 998 | 4961 | 0.2011 | -0.1327 |
MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 3 | M01 | 72 | hr | 1311 | 644 | 4973 | 0.1295 | -0.3092 |
MDA-MB-231 | Neratinib | 0.04 | uM | LJP5 | 1 | A18 | 72 | hr | 1311 | 4876 | 5128 | 0.9508 | 0.9494 |
MDA-MB-231 | Neratinib | 0.04 | uM | LJP5 | 2 | A18 | 72 | hr | 1311 | 4966 | 5100 | 0.9737 | 0.9730 |
MDA-MB-231 | Neratinib | 0.04 | uM | LJP5 | 3 | A18 | 72 | hr | 1311 | 4648 | 5010 | 0.9276 | 0.9237 |
MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 1 | A17 | 72 | hr | 1311 | 5005 | 5128 | 0.9760 | 0.9754 |
MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 2 | A17 | 72 | hr | 1311 | 4876 | 5100 | 0.9561 | 0.9547 |
MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 3 | A17 | 72 | hr | 1311 | 4472 | 5010 | 0.8925 | 0.8857 |